VOYA INVESTMENT MANAGEMENT LLC
Position in EWTX — Edgewise Therapeutics, Inc.
CIK 1068837
ATLANTA, GA
Position in EWTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,233,319
+$249,455 QoQ
Shares Held
39,153
-1.2% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 30.209690189768345.ToString("F0")%
None 69.79030981023165.ToString("F0")%
Common Shares in EWTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,307,060,416 across 174 Biotechnology names. EWTX ranks #71 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
349,912 | $270,356,007 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
527,047 | $235,347,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
148,488 | $49,130,223 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
454,383 | $47,891,967 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
656,129 | $41,139,286 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
538,980 | $40,024,653 | |
| 7 | INSM |
INSMED Inc
|
243,706 | $39,850,804 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
725,409 | $35,661,105 |
All Filings in EWTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,233,319 | 39,153 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $983,864 | 39,648 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $201,403 | 12,417 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $261,059 | 19,913 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,176,170 | 280,735 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $7,586,749 | 284,148 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $8,216,302 | 307,842 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $438,021 | 24,321 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $333,719 | 18,296 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $198,943 | 18,185 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $104,200 | 18,185 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $135,291 | 17,457 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $90,765 | 13,608 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $121,655 | 13,608 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $116,909 | 11,881 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $94,572 | 11,881 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $143,560 | 14,800 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $207,609 | 13,587 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||